Back to Trades
Total Value
$27.9M
Net $20.2M sold
Filing Date
Jul 17, 2026
9 transactions
Sales
$20.2M
9 transactions
Trade Summary
On Jul 17, 2026, OYLER JOHN, Chief Executive Officer, Director, sold $27.9M of BeOne Medicines Ltd. (ONC) across 9 transactions. The filing covers company securities and reflects net selling of $20.2M. Reported prices ranged from $119.96 to $315.06. Insider transactions are sourced from SEC Form 4 disclosures and should be reviewed alongside company fundamentals and the insider's broader trading history.
Company Information
- Company Name
- BeOne Medicines Ltd.
- Ticker Symbol
- ONC
- CIK
- 0001651308
Insider Information
- Name
- OYLER JOHN
- Role
- Chief Executive Officer, Director
Filing Details
- Filing Date
- Jul 17, 2026
- Transaction Date
- Jul 17, 2026
- Accession Number
- 0001042047-26-000015
- Form Type
- 4
- Net Trading Amount
- -$20.2M
Non-Derivative Transactions
| Date | Security | Shares | Price | Type | Value |
|---|---|---|---|---|---|
| Jul 17, 2026 | ONC common stock | 64,628 | $119.96 | Exercise | $7.8M |
| Jul 17, 2026 | ONC common stock | 1,440 | $305.20 | Sale | $439.5K |
| Jul 17, 2026 | ONC common stock | 597 | $306.96 | Sale | $183.3K |
| Jul 17, 2026 | ONC common stock | 680 | $309.05 | Sale | $210.2K |
| Jul 17, 2026 | ONC common stock | 4,833 | $310.37 | Sale | $1.5M |
| Jul 17, 2026 | ONC common stock | 5,543 | $311.42 | Sale | $1.7M |
| Jul 17, 2026 | ONC common stock | 35,829 | $312.17 | Sale | $11.2M |
| Jul 17, 2026 | ONC common stock | 14,915 | $313.19 | Sale | $4.7M |
| Jul 17, 2026 | ONC common stock | 740 | $314.32 | Sale | $232.6K |
| Jul 17, 2026 | ONC common stock | 51 | $315.06 | Sale | $16.1K |
Derivative Transactions
| Date | Security | Shares | Exercise Price | Type | Value |
|---|---|---|---|---|---|
| Jul 17, 2026 | ONC derivative | 840,164 | — | Exercise | — |
Want live alerts when OYLER JOHN trades again?
Download Insider Trades to track ONC, follow insiders, and get mobile alerts when new SEC Form 4 filings are published.
Footnotes
- (F1)These securities are held by the P&O Trust, the beneficiaries of which include the Reporting Person's child and others, for which the Reporting Person disclaims beneficial ownership.
- (F2)These securities are held in a grantor retained annuity trust, of which the Reporting Person's father is a trustee, for which the Reporting Person disclaims beneficial ownership.
- (F3)These securities are held by Oyler Investment LLC, of which 99% of the the limited liability company interests are owned by a grantor retain annuity trust, of which the Reporting Person's father is a trustee, for which the Reporting Person disclaims beneficial ownership.
- (F4)These securities are held for the benefit of the Reporting Person in a Roth IRA PENSCO trust account.
- (F5)These securities are held by The John Oyler Legacy Trust for the benefit of the Reporting Person's child, for which the Reporting Person disclaims beneficial ownership.
- (F6)Each American Depositary Share represents 13 Ordinary Shares.
- (F7)The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 10, 2026.
- (F8)The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $304.96 to $305.605, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.
- (F9)The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $306.61 to $307.59, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.
- (F10)The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $308.77 to $309.37, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.
- (F11)The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $309.78 to $310.76, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.
- (F12)The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $310.78 to $311.77, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.
- (F13)The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $311.78 to $312.77, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.
- (F14)The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $312.78 to $313.76, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.
- (F15)The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $313.83 to $314.67, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.
- (F16)The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $314.88 to $315.18, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.
- (F17)The number of securities underlying each option and the exercise price therefore are represented in ordinary shares.
- (F18)These securities vest over a four-year period as follows: 25% on June 5, 2020, and the remaining in 36 successive equal monthly installments, subject to continued service. Unvested shares are subject to accelerated vesting upon a change in control or certain termination events.